公开(公告)号：US20100003319A1

公开(公告)日：2010-01-07

申请号：US12494349

申请日：2009-06-30

Applicant: Pavak Mehta ,  Kamal Mehta ,  Abhijeet Upadhye

Inventor： Pavak Mehta ,  Kamal Mehta ,  Abhijeet Upadhye

IPC: A61K9/20 ,  A61K31/4535 ,  A61K9/16

CPC classification number: A61K31/4535 ,  A61K9/2018

Abstract: The present invention relates generally to formulations containing raloxifene or pharmaceutical salts thereof, as the active pharmaceutical ingredient and a process for preparing the same.

Abstract translation: 本发明一般涉及含有雷洛昔芬或其药用盐作为活性药物成分的制剂及其制备方法。

公开(公告)号：US20060013876A1

公开(公告)日：2006-01-19

申请号：US10518909

申请日：2003-06-25

Applicant: Braj Lohray ,  Sandip Tiwari ,  Raveendra Pai ,  Krishna Murthy ,  Pavak Mehta

Inventor： Braj Lohray ,  Sandip Tiwari ,  Raveendra Pai ,  Krishna Murthy ,  Pavak Mehta

IPC: A61K9/24

CPC classification number: A61K9/0065

Abstract: Present invention relates to a novel pharmaceutical composition containing an active ingredient(s) which is retained in the stomach or upper part of gastrointestinal tract for controlled delivery of medicament for improved local treatment, and/or better absorption from upper parts of gastrointestinal tract for effective therapeutic results. Present invention also provides a method for preparation of the said dosage form preferably in the form of a bilayer tablet, in which one layer constitutes for spatial control and the other being for temporal control.

Abstract translation: 本发明涉及含有活性成分的新型药物组合物，其保留在胃或胃肠道上部，用于控制递送用于改善局部治疗的药物和/或从胃肠道上部更好地吸收以有效地 治疗结果。 本发明还提供了优选以双层片剂形式制备所述剂型的方法，其中一层构成用于空间控制，另一层构成用于时间控制。

公开(公告)号：US20090324728A1

公开(公告)日：2009-12-31

申请号：US12553409

申请日：2009-09-03

Applicant: Indu Bhushan ,  Kavita Vermani ,  Ravinder Kodipyaka ,  Pavak Mehta ,  Mailatur Sivaraman Mohan

Inventor： Indu Bhushan ,  Kavita Vermani ,  Ravinder Kodipyaka ,  Pavak Mehta ,  Mailatur Sivaraman Mohan

IPC: A61K9/14 ,  A61K31/435

CPC classification number: C07D401/12 ,  A61K9/5078 ,  A61K9/5089 ,  A61K31/4184 ,  A61K31/4439

Abstract: Compositions comprising amorphous substituted benzimidazole compounds.

Abstract translation: 包含非晶取代的苯并咪唑化合物的组合物。

公开(公告)号：US20080146615A1

公开(公告)日：2008-06-19

申请号：US11722247

申请日：2005-12-20

Applicant: Indu Bhushan ,  Kavita Vermani ,  Ravinder Kodipyaka ,  Pavak Mehta ,  Mailatur Sivaraman Mohan

Inventor： Indu Bhushan ,  Kavita Vermani ,  Ravinder Kodipyaka ,  Pavak Mehta ,  Mailatur Sivaraman Mohan

IPC: A61K31/4439 ,  A61K31/4184

CPC classification number: C07D401/12 ,  A61K9/5078 ,  A61K9/5089 ,  A61K31/4184 ,  A61K31/4439

Abstract: Compositions comprising amorphous substituted benzimidazole compounds.

Abstract translation: 包含非晶取代的苯并咪唑化合物的组合物。

公开(公告)号：US20070224260A1

公开(公告)日：2007-09-27

申请号：US10599907

申请日：2005-04-14

Applicant: Pavak Mehta ,  Indu Bhushan ,  Pasula Chowdary ,  Kiran Krishnan ,  Mailatur Mohan

Inventor： Pavak Mehta ,  Indu Bhushan ,  Pasula Chowdary ,  Kiran Krishnan ,  Mailatur Mohan

IPC: A61K9/48 ,  A61K9/20

CPC classification number: A61K9/2072 ,  A61K9/2009 ,  A61K9/2018 ,  A61K9/2095 ,  A61K9/2846 ,  A61K9/2873 ,  A61K9/2886 ,  A61K9/4808

Abstract: Mini-tablets comprising a drug substance are formed by compression, using forces sufficiently low to preserve the polymorphic form of the drug. The mini-tablets can be administered directly, filled into capsules, etc.

Abstract translation: 包含药物的迷你片剂通过压缩形成，使用足够低的力以保持药物的多晶型。 迷你片可直接使用，装入胶囊等。